Genetic variants in the GJB2 gene which encodes for the Connexin 26 protein account for ∼ 60% of cases of genetic hearing loss. A novel hiPSC line was generated from an individual with the hearing loss-related variant c.109G > A in GJB2 leading to the p.V37I alteration in the Connexin26 protein. These cells will help to delineate the role of GJB2 in hearing loss pathogenesis and serve as a platform for drug discovery and development.
Pubmed ID: 34883447 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Commercial organization for research and development genomics services and technical support to researchers.
View all literature mentionsThis monoclonal targets Human SOX17
View all literature mentionsThis monoclonal targets SOX1 antibody [EPR4766]
View all literature mentionsThis polyclonal targets Brachyury / Bry - Mesoderm Marker
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Nanog
View all literature mentionsThis monoclonal targets Sox2
View all literature mentionsThis monoclonal targets Oct-4A (C30A3)
View all literature mentions